Literature DB >> 32262664

The control of epidermal growth factor grafted on mesoporous silica nanoparticles for targeted delivery.

Xiaodong She1, Lijue Chen, Leonora Velleman, Chengpeng Li, Canzhong He, John Denman, Tao Wang, Sarah Shigdar, Wei Duan, Lingxue Kong.   

Abstract

The performance of biomaterials in a biological environment is largely influenced by the surface properties of the biomaterials. In particular, grafted targeting ligands significantly impact the subsequent cellular interactions. The utilisation of a grafted epidermal growth factor (EGF) is effective for targeted delivery of drugs to tumours, but the amount of these biological attachments cannot be easily quantified as most characterization methods could not detect the extremely low amount of EGF ligands grafted on the surface of nanoparticles. In this study, hollow mesoporous silica nanoparticles (HMSNs) were functionalized with amine groups to conjugate with EGFs via carbodiimide chemistry. Time of flight secondary ion mass spectrometry (ToF-SIMS), a very surface specific technique (penetration depth <1.5 nm), was employed to study the binding efficiency of the EGF to the nanoparticles. Principal component analysis (PCA) was implemented to track the relative surface concentrations of EGFs on HMSNs. It was found that ToF-SIMS combined with the PCA technique is an effective method to evaluate the immobilization efficiency of EGFs. Based on this useful technique, the quantity and density of the EGF attachments that grafted on nanoparticles can be effectively controlled by varying the EGF concentration at grafting stages. Cell experiments demonstrated that the targeting performance of EGFR positive cells was affected by the number of EGFs attached on HMSNs.

Entities:  

Year:  2015        PMID: 32262664     DOI: 10.1039/c5tb00790a

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  2 in total

Review 1.  Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release.

Authors:  Avelino Corma; Pablo Botella; Eva Rivero-Buceta
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321

Review 2.  The Application of Inorganic Nanoparticles in Molecular Targeted Cancer Therapy: EGFR Targeting.

Authors:  Meng Sun; Ting Wang; Leijiao Li; Xiangyang Li; Yutong Zhai; Jiantao Zhang; Wenliang Li
Journal:  Front Pharmacol       Date:  2021-07-12       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.